Amed Co Ltd
Amed Co Ltd has a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing relative to equity. The company's liquidity is assessed as medium, with a negative net cash position after subtracting total debt, suggesting potential short-term liquidity constraints. In terms of profitability, Amed Co Ltd's operating cash flow of TWD 18.88 million indicates positive cash generation from operations, though the magnitude is relatively modest given the company's revenue of TWD 821.96 million. The company's capital expenditure of TWD -27.14 million suggests a net outflow for investment in long-term assets, which may support future growth but could also pressure short-term liquidity. Amed Co Ltd's revenue is derived from three main segments: wound care, pain-free medical, and medical device support. The company operates both domestically and internationally, though the input data does not specify the geographic breakdown of revenue. The lack of detailed geographic exposure data limits the ability to assess regional concentration risk. The company's growth trajectory is not explicitly quantified in the input data, but the presence of three distinct business platforms suggests a diversified approach to market expansion. The outlook for the current fiscal year is not provided, but the company's recent financial performance indicates a need to balance investment in growth initiatives with maintaining liquidity. Amed Co Ltd's risk assessment highlights medium liquidity risk and low dilution risk. The company's debt structure, with long-term debt of TWD 505.23 million, suggests a focus on long-term financing. The absence of dilution risk indicates that the company has not issued additional shares recently, and there is no indication of imminent share issuance. Recent events, such as filings or transcripts, are not detailed in the input data, limiting the ability to assess the company's strategic direction or operational developments. The company's financial disclosures provide a baseline for understanding its capital structure and liquidity position, but more granular data is required for a comprehensive analysis.
Business. Amed Co Ltd is a Taiwan-based company engaged in medical-related business, operating three main platforms: wound care, pain-free medical, and medical device support.
Classification. Amed Co Ltd is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.
- Amed Co Ltd maintains a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing.
- The company's operating cash flow of TWD 18.88 million supports its operations but is relatively modest compared to its revenue.
- Amed Co Ltd's capital expenditure of TWD -27.14 million suggests investment in long-term assets, which may support future growth.
- The company's liquidity is assessed as medium, with a negative net cash position after subtracting total debt.
- Amed Co Ltd's risk assessment indicates low dilution risk and medium liquidity risk.
- The company's business is diversified across three platforms, but detailed geographic exposure data is not provided.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.